Back to Stocks

PROF

Profound Medical Corp.
7 filings tracked
healthcaremedical devicesSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Profound Medical has reached a critical commercial inflection point, reporting a 104% year-over-year revenue surge to $5.3 million for the first quarter of 2026.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline revenue growth, Profound Medical continues to struggle with a fundamental cash-burn problem, losing $7.1 million in the first quarter alone.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every PROF filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a company in a high-stakes transition from R&D to commercial scale. The dramatic top-line growth and narrowing net losses provide a compelling narrative of early success, yet the underlying financials reveal a precarious balance between aggressive expansion and cash preservation. The primary tension for investors lies in whether the current surge in capital equipment sales will successfully seed a predictable, high-margin recurring revenue stream before the $50 million cash cushion is depleted. While the reduction in SG&A and the maintenance of 72% gross margins are positive signals of efficiency, the company's reliance on a revolving credit line and the volatility of foreign exchange gains add layers of risk. Ultimately, the filing suggests that while the technology is gaining market traction, the path to self-sufficiency remains steep, requiring consistent execution in device uptake to avoid further dilution or liquidity constraints.

Selected Quarter

Core Takeaway

Profound is successfully growing its top line and improving margins, but it remains a pre-profit company with a narrowing cash runway.

Investor Lens

The trade-off between impressive top-line acceleration and the risk of a liquidity crunch before reaching break-even.

Watch Next

The ratio of recurring-non-capital revenue to total revenue in the next quarterly filing.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.25Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%
bullishMay 7

Revenue increased by 104% year-over-year to $5.3 million.

earnings beat
90%
bullishMay 7

Gross margins remained robust at 72% while SG&A expenses decreased by 20%.

margin expansion
70%
bearishMay 7

Company continues to report significant net losses, totaling $7.1 million for the quarter.

earnings miss
60%
neutralMay 7

Company is managing a revolving credit facility with specific cash and revenue covenants.

debt restructure
50%

Filing History

10-QMay 7, 2026
Expand Sequence

The Q1 2026 filing presents a company in a high-stakes transition from R&D to commercial scale. The dramatic top-line growth and narrowing net losses provide a compelling narrative of early success, yet the underlying financials reveal a precarious balance between aggressive expansion and cash preservation. The primary tension for investors lies in whether the current surge in capital equipment sales will successfully seed a predictable, high-margin recurring revenue stream before the $50 million cash cushion is depleted. While the reduction in SG&A and the maintenance of 72% gross margins are positive signals of efficiency, the company's reliance on a revolving credit line and the volatility of foreign exchange gains add layers of risk. Ultimately, the filing suggests that while the technology is gaining market traction, the path to self-sufficiency remains steep, requiring consistent execution in device uptake to avoid further dilution or liquidity constraints.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.